The platelet P2Y receptors as targets for new antithrombotic drugs

被引：16
作者：
Cattaneo, M [1 ]
机构：
[1] Univ Milan, Osped San Paulo, Unit Hematol & Thrombosis, DMCO,Dept Surg Med & Dent, I-20142 Milan, Italy
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2003年 / 1卷 / 06期
关键词：
D O I：
10.1046/j.1538-7836.2003.00286.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1133 / 1135
页数：3
相关论文
共 28 条
  • [1] Thrombotic thrombocytopenic purpura associated with clopidogrel.
    Bennett, CL
    Connors, JM
    Carwile, JM
    Moake, JL
    Bell, WR
    Tarantolo, SR
    McCarthy, LJ
    Sarode, R
    Hatfield, AJ
    Feldman, MD
    Davidson, CJ
    Tsai, HM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) : 1773 - 1777
  • [2] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817
  • [3] CATTANEO M, 1992, BLOOD, V80, P2787
  • [4] ROLE OF ADP IN PLATELET-AGGREGATION AT HIGH-SHEAR - STUDIES IN A PATIENT WITH CONGENITAL DEFECT OF PLATELET RESPONSES TO ADP
    CATTANEO, M
    ZIGHETTI, ML
    LOMBARDI, R
    MANNUCCI, PM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) : 826 - 829
  • [5] Cattaneo M, 2001, BLOOD, V98, p239A
  • [6] ADP receptors and clinical bleeding disorders
    Cattaneo, M
    Gachet, C
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) : 2281 - 2285
  • [7] SHEAR-INDUCED PLATELET-AGGREGATION IS POTENTIATED BY DESMOPRESSIN AND INHIBITED BY TICLOPIDINE
    CATTANEO, M
    LOMBARDI, R
    BETTEGA, D
    LECCHI, A
    MANNUCCI, PM
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (03): : 393 - 397
  • [8] The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin
    Clarke, TA
    Waskell, LA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 53 - 59
  • [9] Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    Eikelboom, JW
    Hirsh, J
    Weitz, JI
    Johnston, M
    Yi, Q
    Yusuf, S
    [J]. CIRCULATION, 2002, 105 (14) : 1650 - 1655
  • [10] Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
    Fabre, JE
    Nguyen, MT
    Latour, A
    Keifer, JA
    Audoly, LP
    Coffman, TM
    Koller, BH
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1199 - 1202
123